| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/07/2009 | CA2704774A1 Keratin derivatives and methods of making same |
| 05/07/2009 | CA2704532A1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 05/07/2009 | CA2704455A1 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection |
| 05/07/2009 | CA2704397A1 Hla-dr binding peptides and their uses |
| 05/07/2009 | CA2704314A1 Polypeptides involved in neuronal regeneration-associated gene expression |
| 05/07/2009 | CA2704296A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | CA2704207A1 Porcine dc-sign, icam-3 and lsectin and uses thereof |
| 05/07/2009 | CA2704144A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | CA2704119A1 Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 05/07/2009 | CA2704092A1 Food material for inhibiting osteoclastogenesis |
| 05/07/2009 | CA2704065A1 Insect inhibiting plant serpin mutants |
| 05/07/2009 | CA2704042A1 Bone resorption inhibitory food material for inhibiting bone resorption |
| 05/07/2009 | CA2703948A1 Recombinant factor viii having increased stability |
| 05/07/2009 | CA2703827A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/07/2009 | CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs |
| 05/07/2009 | CA2703770A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 05/07/2009 | CA2703701A1 Resistance gene and uses thereof |
| 05/07/2009 | CA2703393A1 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 05/07/2009 | CA2703263A1 Immunosuppressive polypeptides and nucleic acids |
| 05/07/2009 | CA2703151A1 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 05/07/2009 | CA2702697A1 Engineered pertactin variants for vaccine use |
| 05/07/2009 | CA2702289A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 05/07/2009 | CA2693307A1 Lantibiotics and uses thereof |
| 05/06/2009 | EP2056112A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
| 05/06/2009 | EP2055783A1 Insect inhibiting plant serpin mutants |
| 05/06/2009 | EP2055780A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 05/06/2009 | EP2055779A2 Auxin transport proteins |
| 05/06/2009 | EP2055778A1 Mutant plant and method for production thereof |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055715A1 Anticomplement polypeptides of ixodes ricinus |
| 05/06/2009 | EP2055714A2 Biological photo-receptors as directly light-controlled ion channels and their use |
| 05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
| 05/06/2009 | EP2055712A1 Peptides and compounds that bind to a thrombopoietin receptor |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055189A1 Glycopegylation methods and proteins/peptides produced by the methods |
| 05/06/2009 | EP2054521A2 Methods for the purification of polypeptide conjugates |
| 05/06/2009 | EP2054516A2 Plants having improved characteristics and a method for making the same |
| 05/06/2009 | EP2054441A1 Soluble il-27 receptor |
| 05/06/2009 | EP2054440A2 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin 5 1, having proangiogenic activity |
| 05/06/2009 | EP2054439A1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 05/06/2009 | EP2054438A1 Truncated pth peptides with a cyclic conformation |
| 05/06/2009 | EP2054437A2 Albumin-insulin fusion proteins |
| 05/06/2009 | EP2054436A1 Transglutaminase variants with improved specificity |
| 05/06/2009 | EP2054435A1 Transglutaminase variants with improved specificity |
| 05/06/2009 | EP2054434A1 Myostatin antagonists |
| 05/06/2009 | EP2054433A1 Diuretic and natriuretic polypeptides |
| 05/06/2009 | EP2054432A2 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 05/06/2009 | EP2054431A2 Conformers of bacterial adhesins |
| 05/06/2009 | EP2054430A2 Promiscuous her-2/neu cd4 t cell epitopes |
| 05/06/2009 | EP2054082A2 Therapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 05/06/2009 | EP2054077A2 Polypeptide derivatives of parathyroid hormone (pth) |
| 05/06/2009 | EP2054074A1 Modified erythropoietin |
| 05/06/2009 | EP2054044A1 Medicament for lct poisoning |
| 05/06/2009 | EP1976992A4 Methods and compositions for the detection and isolation of ligands |
| 05/06/2009 | EP1899375A4 New purification method of lactoferrin |
| 05/06/2009 | EP1848830A4 Osplation of pathogenic prions |
| 05/06/2009 | EP1745069B1 Therapeutic use of growth factor nsg33 |
| 05/06/2009 | EP1556404B1 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 05/06/2009 | EP1539785B1 Gene regulation in transgenic animals using a transposon-based vector |
| 05/06/2009 | EP1537206B1 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 05/06/2009 | EP1513415B1 Colour reduction in canola protein isolate |
| 05/06/2009 | EP1379671B1 Methods to culture circovirus |
| 05/06/2009 | EP1274851B1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 05/06/2009 | EP1224271B1 Expression of recombinant mature lysostaphin |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1094115B1 (-)-strand rna virus vector for nerve cells |
| 05/06/2009 | EP0742824B1 Wd-40-derived peptides and uses thereof |
| 05/06/2009 | CN101426920A Pathogen-inducible synthetic promoter |
| 05/06/2009 | CN101426916A Improved interleukin-2 muteins |
| 05/06/2009 | CN101426912A Chemically modified short interfering nucleic acid molecules that mediate RNA interference |
| 05/06/2009 | CN101426907A Cloning and expression of a novel phytase |
| 05/06/2009 | CN101426902A Method for differentiation induction of myocardial cell from pluripotent stem cell |
| 05/06/2009 | CN101426816A Antibodies against human il-22 and uses therefor |
| 05/06/2009 | CN101426814A Compositions and methods for humanization and optimization of N-glycans in plants |
| 05/06/2009 | CN101426813A Immunomodulatory and anti-tumour peptides |
| 05/06/2009 | CN101426812A Methods for altering protein production rates |
| 05/06/2009 | CN101426811A Hpv-16-based papillomavirus vaccine |
| 05/06/2009 | CN101426810A Hpv-18-based papillomavirus vaccine |
| 05/06/2009 | CN101426533A Immunostimulatory compositions and methods |
| 05/06/2009 | CN101426532A In vivo cell surface engineering |
| 05/06/2009 | CN101426525A Chimeric vaccine antigens against classical swine fever virus |
| 05/06/2009 | CN101426518A Methods and compositions for treating asthma in human and non human primates |
| 05/06/2009 | CN101426515A Novel enterococcus and streptococcus strains and bacteriocins |
| 05/06/2009 | CN101426514A HCV vaccines |
| 05/06/2009 | CN101426511A Chemically-modified progenipoietin conjugates |
| 05/06/2009 | CN101423837A Biological synthesis gene cluster of siomycin |
| 05/06/2009 | CN101423833A Method for preparing inhibin genetic engineering regulation antigen |
| 05/06/2009 | CN101423553A Human monoclonal antibodies to dendritic cells |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423550A Genetic engineering immunosuppressive polypeptide and preparation method and application |
| 05/06/2009 | CN101423549A Ibtip1 gene from sweet potato root and promoter thereof |
| 05/06/2009 | CN101423548A Preparation of duck hepatitis I type virus indirect hemagglutination diagnostic antigen and kit |
| 05/06/2009 | CN101422485A Preparation method of spleen byproducts for producing homology anti-serum blood and transfer factor from fox, raccoon dog, mink |
| 05/06/2009 | CN100485038C Miniaturized Staphylococcus aureus polypeptide of against drug-resistance and its uses and preparation method |
| 05/06/2009 | CN100485036C Fennero penaeus chinensis antibacterial protein gene and recombinant expression and use |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100484959C Modified recombinant porcine alpha interferon protein and coding gene and uses thereof |